Larvol Veri

BIOMARKER:

JAK2 underexpression

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

JAK2 underexpression JAK2 underexpression	Cutaneous Melanoma Cutaneous Melanoma	TL-1-85 Sensitive: C3 – Early Trials TL-1-85 Sensitive : C3
JAK2 underexpression JAK2 underexpression	Cutaneous Melanoma Cutaneous Melanoma	QL-VIII-58 Sensitive: C3 – Early Trials QL-VIII-58 Sensitive : C3
JAK2 underexpression JAK2 underexpression	Cutaneous Melanoma Cutaneous Melanoma	ruxolitinib Resistant: C3 – Early Trials ruxolitinib Resistant : C3
JAK2 underexpression JAK2 underexpression	Cutaneous Melanoma Cutaneous Melanoma	fedratinib Resistant: C3 – Early Trials fedratinib Resistant : C3
JAK2 underexpression JAK2 underexpression	Cutaneous Melanoma Cutaneous Melanoma	sunitinib Resistant: C3 – Early Trials sunitinib Resistant : C3